Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|August 11, 2021
Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of Transplanted KidneysMichiel G H Betjes, Marcia M L Kho, Nicolle H R Litjens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2010
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantationLennaert C P Borra, Joke I Roodnat, Judith A Kal, et al.
Therapeutic Drug Monitoring|September 30, 2014
Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposureNauras Shuker, Monique Cadogan, Teun van Gelder, et al.
Therapeutic Drug Monitoring|May 14, 2011
CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearanceNilufar Pashaee, Rachida Bouamar, Dennis A Hesselink, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 21, 2008
Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and deathJeroen Aalten, Ellen K Hoogeveen, Joke I Roodnat, et al.
Transplantation|June 14, 2014
Understanding the influence of ethnicity and socioeconomic factors on graft and patient survival after kidney transplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 7, 2012
The relative importance of donor age in deceased and living donor kidney transplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 9, 2020
The prognosis of kidney transplant recipients with aorto-iliac calcification: a systematic review and meta-analysisElsaline Rijkse, Jacob L van Dam, Joke I Roodnat, et al.
Transplantation|May 10, 2005
The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantationFrancine B C Lemos, Wendy M Mol, Joke I Roodnat, et al.
Pharmacological Research|March 21, 2021
Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipientsWieteke Kleinherenbrink, Marije Baas, Gizal Nakhsbandi, et al.
Pageof 6